BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37293163)

  • 21. Long non-coding RNA Linc00662 promotes cell invasion and contributes to cancer stem cell-like phenotypes in lung cancer cells.
    Gong W; Su Y; Liu Y; Sun P; Wang X
    J Biochem; 2018 Dec; 164(6):461-469. PubMed ID: 30256974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LINC00662 promotes hepatocellular carcinoma progression via altering genomic methylation profiles.
    Guo T; Gong C; Wu P; Battaglia-Hsu SF; Feng J; Liu P; Wang H; Guo D; Yao Y; Chen B; Xiao Y; Liu Z; Li Z
    Cell Death Differ; 2020 Jul; 27(7):2191-2205. PubMed ID: 31959915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bile acids-mediated overexpression of MUC4 via FAK-dependent c-Jun activation in pancreatic cancer.
    Joshi S; Cruz E; Rachagani S; Guha S; Brand RE; Ponnusamy MP; Kumar S; Batra SK
    Mol Oncol; 2016 Aug; 10(7):1063-77. PubMed ID: 27185392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long noncoding RNA LINC00662 functions as miRNA sponge to promote the prostate cancer tumorigenesis through targeting miR-34a.
    Li N; Zhang LY; Qiao YH; Song RJ
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3688-3698. PubMed ID: 31114993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LncRNA LINC00662 Exerts an Oncogenic Effect on Osteosarcoma by the miR-16-5p/ITPR1 Axis.
    Yu M; Lu W; Cao Z; Xuan T
    J Oncol; 2021; 2021():8493431. PubMed ID: 34621314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LINC00662 enhances cell progression and stemness in breast cancer by MiR-144-3p/SOX2 axis.
    An C; Hu Z; Li Y; Zhao P; Liu R; Zhang Q; Zhu P; Li Y; Wang Y
    Cancer Cell Int; 2022 May; 22(1):184. PubMed ID: 35551606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. METTL3 facilitates tumor progression via an m
    Li T; Hu PS; Zuo Z; Lin JF; Li X; Wu QN; Chen ZH; Zeng ZL; Wang F; Zheng J; Chen D; Li B; Kang TB; Xie D; Lin D; Ju HQ; Xu RH
    Mol Cancer; 2019 Jun; 18(1):112. PubMed ID: 31230592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LINC00662 promotes cell viability and metastasis in esophageal squamous cell carcinoma by sponging miR-340-5p and upregulating HOXB2.
    Zhang Z; Liang X; Ren L; Zhang S; Li S; Wan T; Xu D; Lv S
    Thorac Cancer; 2020 Aug; 11(8):2306-2315. PubMed ID: 32633082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Axed MUC4 (MUC4/X) aggravates pancreatic malignant phenotype by activating integrin-β1/FAK/ERK pathway.
    Jahan R; Macha MA; Rachagani S; Das S; Smith LM; Kaur S; Batra SK
    Biochim Biophys Acta Mol Basis Dis; 2018 Aug; 1864(8):2538-2549. PubMed ID: 29777904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Vital Roles of LINC00662 in Human Cancers.
    He Y; Xu Y; Yu X; Sun Z; Guo W
    Front Cell Dev Biol; 2021; 9():711352. PubMed ID: 34354995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N6-methyladenosine-mediated CELF2 regulates CD44 alternative splicing affecting tumorigenesis via ERAD pathway in pancreatic cancer.
    Lai S; Wang Y; Li T; Dong Y; Lin Y; Wang L; Weng S; Zhang X; Lin C
    Cell Biosci; 2022 Aug; 12(1):125. PubMed ID: 35941702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HOXB5 promotes malignant progression in pancreatic cancer via the miR-6732 pathway.
    Li ZX; Wu G; Jiang WJ; Li J; Wang YY; Ju XM; Yin YT
    Cell Cycle; 2020 Jan; 19(2):233-245. PubMed ID: 31876226
    [No Abstract]   [Full Text] [Related]  

  • 33. LINC00662 triggers malignant progression of chordoma by the activation of RNF144B via targeting miR-16-5p.
    Wang CB; Wang Y; Wang JJ; Guo XL
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1007-1022. PubMed ID: 32096180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The RNA N6-Methyladenosine Methyltransferase METTL3 Promotes the Progression of Kidney Cancer via N6-Methyladenosine-Dependent Translational Enhancement of ABCD1.
    Shi Y; Dou Y; Zhang J; Qi J; Xin Z; Zhang M; Xiao Y; Ci W
    Front Cell Dev Biol; 2021; 9():737498. PubMed ID: 34631715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
    Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
    Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nicotine/cigarette smoke promotes metastasis of pancreatic cancer through α7nAChR-mediated MUC4 upregulation.
    Momi N; Ponnusamy MP; Kaur S; Rachagani S; Kunigal SS; Chellappan S; Ouellette MM; Batra SK
    Oncogene; 2013 Mar; 32(11):1384-95. PubMed ID: 22614008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mammary epithelial-specific disruption of focal adhesion kinase retards tumor formation and metastasis in a transgenic mouse model of human breast cancer.
    Provenzano PP; Inman DR; Eliceiri KW; Beggs HE; Keely PJ
    Am J Pathol; 2008 Nov; 173(5):1551-65. PubMed ID: 18845837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. METTL3-mediated m
    Han H; Yang C; Zhang S; Cheng M; Guo S; Zhu Y; Ma J; Liang Y; Wang L; Zheng S; Wang Z; Chen D; Jiang YZ; Lin S
    Mol Ther Nucleic Acids; 2021 Dec; 26():333-346. PubMed ID: 34513313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N
    Wan W; Ao X; Chen Q; Yu Y; Ao L; Xing W; Guo W; Wu X; Pu C; Hu X; Li Z; Yao M; Luo D; Xu X
    Mol Cancer; 2022 Feb; 21(1):60. PubMed ID: 35197058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LINC00662 contributes to the progression and the radioresistance of cervical cancer by regulating miR-497-5p and CDC25A.
    Wei J; Wang L; Sun Y; Bao Y
    Cell Biochem Funct; 2020 Dec; 38(8):1139-1151. PubMed ID: 32869878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.